Modeling familial Alzheimer's disease with induced pluripotent stem cells

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577

Disease-Specific Induced Pluripotent Stem Cells.

Park, I.-H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008) · Cell · doi:10.1016/j.cell.2008.07.041 · Cited by 2,196

Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease

Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078

Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons

Dimos, J. T., Rodolfa, K. T., Niakan, K. K., Weisenthal, L. M., Mitsumoto, H., Chung, W. K., Croft, G. F., Saphier, G., Leibel, R. L., Goland, R., et al. (2008) · Science · doi:10.1126/science.1158799 · Cited by 2,019

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective

Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849

In vitro cell-line models of Alzheimer’s disease: A systematic review and mechanism-based evidence map of induction paradigms, targeted mechanisms, and validation requirements

Alghamdi, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103322 · Cited by 1

Clinical application progress of induced pluripotent stem cells (iPSCs)

HUANG, C., Jiang, S., & Peng, J. (2014) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/972013-894

Human iPSC Models: A Platform for Investigating Neurodevelopmental Diseases

McKinney, C. E. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000122

Pluripotent Stem Cell-Derived Dopaminergic Neurons As Models of Neurodegeneration

Watmuff, B., Hartley, B. J., Hunt, C. P. J., Pouton, C. W., & Haynes, J. M. (2013) · Future Neurology · doi:10.2217/fnl.13.50 · Cited by 1

The Hope for iPSC in Lung Stem Cell Therapy and Disease Modeling

Menon, T., & Firth, A. L. (2015) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-16232-4_7 · Cited by 1

Induced Pluripotent Stem Cells: To Model, To Treat

Wang, H. (2011) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000e103 · Cited by 1

Could Stem Cells Be Used to Treat or Model Alzheimer’s Disease?

Abud, E. M., & Blurton-Jones, M. M. (2016) · Springer eBooks · doi:10.1007/978-1-4899-7654-3_12 · Cited by 1

Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells

Hall, V. J. (2016) · InTech eBooks · doi:10.5772/63521 · Cited by 1

Nontargeted Metabolite Profiling of Induced Pluripotent Stem Cells (iPSCs) Derived Neural Cells: Insights Into Mechanisms of Brain Diseases

Lehtonen, Š., Lehtonen, M., & Koıstınaho, J. (2016) · InTech eBooks · doi:10.5772/62851

Induced Pluripotent Stem Cells for the Treatment of Neurodegenerative Disease: Current and Future Prospects

Kumari, A., Chaudhary, A., & Haque, R. (2022) · Springer eBooks · doi:10.1007/978-981-16-8562-0_5 · Cited by 1

Translational Medicine of Stem Cells: Central Nervous System Regeneration and Modeling Neurological Diseases

Okano, H. (2013) · Springer eBooks · doi:10.1007/978-4-431-54306-0_5 · Cited by 1

2 Human-Induced Pluripotent Stem Cells: Banking and Characterization

Rajamani, U., Lenaeus, L., Ornelas, L., & Sareen, D. (2017) · CRC Press eBooks · doi:10.1201/b21629-2 · Cited by 1

Induced pluripotent stem cells as models of human neurodevelopmental disorders

Jourdon, A., Mariani, J., Scuderi, S., Amiri, A., Wu, F., Yuen, E. Y., Abyzov, A. S., & Vaccarino, F. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-814409-1.00005-7 · Cited by 1

Human iPSCs and their uses in developmental toxicology

Edenfield, R. C., Siracusa, J. S., Wang, R., & Yu, X. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822228-7.00012-6 · Cited by 1

Induced pluripotent stem cell derived from postmortem tissue in neurodegenerative disease research

Rogers, J., Myers, A., & Dykxhoorn, D. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822135-8.00008-2 · Cited by 1

Differentiation of Stem Cells into Neuronal Lineage: In Vitro Cell Culture and In Vivo Transplantation in Animal Models

Siddiqui, S. S., Aboshamat, K., Loganathan, S., & Siddiqui, Z. K. (2021) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-030-78101-9_4 · Cited by 1

How induced pluripotent stem cells changed the research status of polycystic ovary syndrome

Yu, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85765-9.00009-6 · Cited by 1

Modulation of the Nogo signaling pathway to overcome amyloid-β-mediated neurite inhibition in human pluripotent stem cell–derived neurites

Goncalves, K., & Przyborski, S. A. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01628 · Cited by 1

An Introduction to Cellular Reprogramming: The Plasticity of Cell Fates and Identities

Smith, K. P., Borowski, M., & Laning, J. C. (2014) · Wiley eBooks · doi:10.1002/9781118695746.ch8 · Cited by 1

Stem cell tools for compound development

Novak, T. J. (2015) · Wiley eBooks · doi:10.1002/9781118846193.ch10 · Cited by 1

Disease‐Specific Stem Cell Models for Toxicological Screenings and Drug Development

Jung, M., Jung, J., Schiller, J., & Schroeder, I. S. (2016) · Wiley eBooks · doi:10.1002/9781119135449.ch7 · Cited by 1

Induced pluripotent stem cell technologies for tissue engineering

Huang, G. T. ‐., Ayachi, I. E., & Zou, X. (2016) · Wiley eBooks · doi:10.1002/9781119282181.ch1 · Cited by 1

A human embryonic stem cell model of Aβ-dependent chronic progressive neurodegenerationPreprint

Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/419978 · Cited by 1

Single cell transcriptomic profiling of tauopathy in a novel 3D neuron-astrocyte coculture modelPreprint

Rickner, H., Jiang, L., Hong, R., O’Neill, N. K., Mojica, C. A., Snyder, B. J., Zhang, L., Shaw, D., Medalla, M., Wolozin, B. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.03.490513 · Cited by 1

From Human Pluripotent Stem Cells to Neurons: Promises and Pitfalls

Nehme, R., & Madison, J. M. (2014) · Wiley eBooks · doi:10.1002/9780470015902.a0025784

3) iPS Cell Technology for Neurodegenerative Disease

Inoue, H. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.2267

Assays of traditional drugs using human neurons derived from pluripotent stem cells

Ohnuma, K. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.11.021

Genetic and non-genetic factors responsible for mitochondrial failure and Alzheimer’s disease

Gao, K., Niu, M., Zhai, X., Huang, Y., Tian, X., & Li, T. (2014) · Genetika · doi:10.2298/gensr1402631g

Human iPSC Models: A Platform for Investigating Neurodevelopmental

McKinney, D., & Brown, S. (2014)

Influência do cálcio e das proteínas Miro na mobilidade mitocondrial anteriormente e durante a agregação de proteínas envolvidas em neurodegeneração

Chaves, R. D. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-05012016-154631

Use of Induced Pluripotent Stem Cells in Aging Research

Isobe, K. (2015) · Springer eBooks · doi:10.1007/978-4-431-55763-0_4

Ever Young: A Big Game, Induced Pluripotent Stem Cell a Positive Candidate

Sayfullah, M. S. M. (2014) · Biochemistry & Physiology Open Access · doi:10.4172/2168-9652.1000e124

Before and After the Nobel Prize Physiology or Medicine 2012-From Reprogramming to Clinical Application-

Okano, H. (2013) · TRENDS IN THE SCIENCES · doi:10.5363/tits.18.2_13

Cell-Based Therapy in Alzheimer's Disease: Current Knowledge and Perspective

Qiao, L., Qiao, L., Huang, H., Chen, L., Huang, H., & Chen, L. (2016) · Translational Neuroscience and Clinics · doi:10.18679/cn11-6030/r.2016.007

Induced Pluripotent Stem Cell, a Rising Star in Regenerative Medicine

Mao, Y., Wang, Y., Wang, L., & Zhou, Q. (2015) · Translational medicine research · doi:10.1007/978-94-017-7273-0_4

Applications of CRISPR-Cas systems in neuroscience

Harvard, C. (2016)

Progress and Prospects: Induced Pluripotent Stem Cell Research for Neurological Diseases

Ito, D., & Suzuki, N. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.3230

Células estaminais pluripotentes induzidas no estudo de mecanismos de doença e avaliação de novas terapias

Correia, L. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)

Induced Pluripotent Stem Cells Derived from Dental Stem Cells: A New Tool for Cellular Therapy

Kerkis, I., Wenceslau, C. V., & Pompéia, C. (2016) · Stem cell biology and regenerative medicine · doi:10.1007/978-3-319-28947-2_7

Stem Cell Therapy for Alzheimer's DiseasePreprint

Patel, A. A., Joshi, G., & Ugile, R. (2016) · arXiv (Cornell University) · doi:10.48550/arxiv.1608.07499

Induced pluripotent stem cells: methods, disease modeling, and microenvironment for drug discovery and screening

Krishnan, S. (2016) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1507-138

Stem Cell Therapy in Neurological and Neurodegenerative Disease

Lee, H. J., Choi, S. S., Lee, S., & Chang, K. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-33720-3_1

Out with the Old, in with the New… Strategies Based on Stem Cells to Design New Models of Alzheimer’s Disease

Revilla, A. (2017) · Journal of Stem Cell Research & Therapeutics · doi:10.15406/jsrt.2017.02.00060

Engineering antibody therapeutics and cell culture models for neurodegenerative diseases

McHugh, K. P. (2016) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/9ar9-m703

Three-Dimensional Cultures of Human Neural Stem Cells: An Application for Modeling Alzheimer’s Disease Pathogenesis

Choi, S. H., D’Avanzo, C., Kim, Y. H., Bylykbashi, E., Hebisch, M., Brüstle, O., Tanzi, R. E., & Kim, D. Y. (2017) · Neuromethods · doi:10.1007/978-1-4939-7024-7_1

3) iPS Cell Technology for Neurodegenerative Disease

Inoue, H. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.112b

Rett Syndrome Induced Pluripotent Stem Cell-derived Neurons Exhibit Electrophysiological Aberrations

Farra, N. (2012) · TSpace (University of Toronto)

Induced Pluripotent Stem Cell Therapy and Safety Concerns in Age-Related Chronic Neurodegenerative Diseases

Eren, E., Erkan, E. P., Genç, Ş., & Genc, K. K. (2017) · Stem cells in clinical applications · doi:10.1007/978-3-319-59165-0_2

Evaluation of molecular markers in osteogenic differentiation of mesenchymal stem cells

Ishiy, F. A. A. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2017.tde-20032017-104921

Deciphering X-chromosome inactivation and the role of MECP2e1 in Rett Syndrome patient induced pluripotent stem cells

Cheung, A. Y. L. (2013) · TSpace (University of Toronto)

Cellular models of human brain disorders from skin to brain

Shahsavani, M. (2018) · Figshare

Human-Induced Pluripotent Stem Cell-Derived Neurons to Model and Gain Insights into Alzheimer’s Disease Pathogenesis

Young, J. E., & Delgado‐Morales, R. (2018) · Springer eBooks · doi:10.1007/978-3-319-90695-9_1

Modeling Neurological Diseases with Induced Pluripotent Stem Cells

Akamatsu, W. (2018) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.2018.64.jmj18-r04

Modelling the neurobiology of Alzheimer’s disease in vitro

Muñoz, S. S. (2019) · Research Online (University of Wollongong)

Modeling of Alzheimer’s Disease and Outlooks for its Therapy Using Induced Pluripotent Stem Cells

Хаспеков, Л. Г. (2019) · Neurochemical Journal · doi:10.1134/s181971241902003x

Application and Development of Tissue Engineering Technology in the Fields of Cardiac Reconstruction, Nerve Regeneration and Bone Reconstruction

Li, S. (2020) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/740/1/012128

Chemical Probes in Cellular Assays for Target Validation and Screening in Neurodegeneration

Silva, A. M., Cederbalk, A., Ebner, D. V., & Daniel, E. D. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160745-00276

Investigating the role of APOE: limitations of human pluripotent stem cell-derived cerebral organoidsPreprint

Hernández, D. G., Rooney, L. A., Daniszewski, M., Gulluyan, L. M., Liang, H. H., Cook, A. L., Hewitt, A. W., & Pébay, A. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.30.405654

IPSCs-based Modelling of Neurological Diseases and Drug Development

Okano, H. (2019) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.108.2547

Correction of a pathogenic mutation in iPSCs derived from a patient with Christianson syndrome using CRISPR/Cas9 genome editingPreprint

Ma, L., Wu, Q., Schmidt, M., & Morrow, E. M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.20.445025

3D microenvironments for in vitro modeling of alzheimer’s disease

Ranjan, V. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/146832

Combining bioscaffolds and iPSCs in the treatment of neural trauma and Alzheimer’s disease

Brice, R., Kehler, J., & Yao, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85766-6.00007-3

Use of induced pluripotent stem cells to model inflammatory neurodegeneration and repair in multiple sclerosis

Julian, K. A., & Imitola, J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85765-9.00001-1

Neuronal identity and maturation

van den Hurk, M. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20161213mh

Biobanking and Biomarkers in the Alzheimer’s Disease Drug-Development Ecosystem

Kinney, J. W., & Salazar, A. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.011

Finding Cures for Alzheimer's Disease

Huang, X., & Aslanian, R. G. (2022) · Wiley eBooks · doi:10.1002/9781119627784.ch4

2 Human-Induced Pluripotent Stem Cells: Banking and Characterization

Rajamani, U., Lenaeus, L., Ornelas, L., & Sareen, D. (2017) · CRC Press eBooks · doi:10.1201/9781315402185-3

Actual strategies in human induced pluripotent stem cells (hiPSCs) differentiation – perspectives and challenges

Augustyniak, E., Kulcenty, K. I., Lach, M., Piotrowski, I., & Suchorska, W. M. (2016) · Diagnostyka Laboratoryjna · doi:10.5604/01.3001.0009.3643

Faculty Opinions recommendation of Stabilizing the retromer complex in a human stem cell model of Alzheimer's disease reduces TAU phosphorylation independently of amyloid precursor protein.

Evans, K., & Gospodinova, K. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732773136.793567595

References

(2014) · Elsevier eBooks · doi:10.1016/b978-1-907568-42-8.50016-2

Specification and regulation of mammalian extraembryonic and pluripotent embryonic lineages in vivo and in vitro

Blij, S. (2014) · eScholarship (California Digital Library)

Advantages and limitations of hiPSC-derived neurons for the study of neurodegeneration

Mishra, S., Deursen, C. V., Robert, A., van der Kant, R., & Young, J. E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822277-5.00016-x

Stem cell therapy as a novel concept to combat CNS disorders

Kumar, R., Mahajan, S., Gupta, U., Madan, J., Godugu, C., Guru, S. K., Singh, P. K., Parvatikar, P., & Maji, I. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00009-1

iPSC-derived skeletal muscle spheroids for Duchenne Muscular Dystrophy modeling

Esposito, J., Leite, F. D. S., Barbosa, I. N., Martins, T. M. D. M., Olberg, G. G. D. O., Tanoury, Z. A., Telles-Silva, K. A., Pardo, M. C. D. S., Jazedje, T., Bortolin, R. H., et al. (2026) · Skeletal Muscle · doi:10.1186/s13395-026-00428-3

Generation of APOE ε3/ε4 and APP-mutant human pluripotent stem cell line derived from an Alzheimer’s patient

Zhai, Y., Cheng, J., Guo, X., Wang, X., Ma, M., Wang, S., & Ren, Q. (2025) · Stem Cell Research · doi:10.1016/j.scr.2025.103787

Cellular models of chronic diseases: From bench to bedside

Tiwari, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33877-9.00015-x

Alzheimer’s disease PSEN-2 N141I mutation reveals altered and shear-sensitive brain endothelial cell-like phenotype in human iPSC-derived models

Takeuchi, L. E., Lam, J., & Simmons, C. A. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02152-3

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer’s disease immunotherapy

Chinnathambi, S., Adityan, A., Chandrashekar, M., & Velmurugan, G. (2025) · Advances in immunology · doi:10.1016/bs.ai.2025.11.001 · Cited by 1

Stem Cell Therapy for Neurological Disorders: From Bench to Bedside

Barbuti, P. A. (2014) · Springer eBooks · doi:10.1007/978-81-322-2110-4_4

Additional file 1 of Presence of a mutation in PSEN1 or PSEN2 gene is associated with an impaired brain endothelial cell phenotype in vitro

Raut, S., Patel, R., & Al-Ahmad, A. J. (2021) · Figshare · doi:10.6084/m9.figshare.13545554

Additional file 4 of Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed the astrocytic phenotypes of Alzheimer’s disease

Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Figshare · doi:10.6084/m9.figshare.26686686

Additional file 2 of Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed the astrocytic phenotypes of Alzheimer’s disease

Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Figshare · doi:10.6084/m9.figshare.26686680

Additional file 1 of Presenilin-1 F105C mutation leads to tau accumulation in human neurons via the Akt/mTORC1 signaling pathway

Chong, C.-M., Tan, Y., Tong, J., Ke, M., Zhang, K., Yan, L., Cen, X., Lu, J., Chen, G., Su, H., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20488689

Additional file 3 of Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed the astrocytic phenotypes of Alzheimer’s disease

Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Figshare · doi:10.6084/m9.figshare.26686683

Additional file 1 of Expression of ACE2 and a viral virulence-regulating factor CCN family member 1 in human iPSC-derived neural cells: implications for COVID-19-related CNS disorders

Kase, Y., & Okano, H. (2020) · Figshare · doi:10.6084/m9.figshare.12947656

Additional file 1 of Mutual interaction of neurons and astrocytes derived from iPSCs with APP V717L mutation developed the astrocytic phenotypes of Alzheimer’s disease

Supakul, S., Murakami, R., Oyama, C., Shindo, T., Hatakeyama, Y., Itsuno, M., Bannai, H., Shibata, S., Maeda, S., & Okano, H. (2024) · Figshare · doi:10.6084/m9.figshare.26686677

Additional file 1 of 3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer’s disease using a smart bioink

Benwood, C., Walters-Shumka, J. P., Scheck, K., & Willerth, S. M. (2023) · Figshare · doi:10.6084/m9.figshare.23118946

Induced-pluripotent stem cell-derived immunotherapy for Tau and Alzheimer’s disease

Chinnathambi, S. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.005

From mice to clinical relevance: humanizing neuroscience with human-based model systems

Bak, A., van Loo, K. M. J., Kronenberg‐Versteeg, D., & Koch, H. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1776439

Hépatocytes différenciés à partir de cellules souches pluripotentes induites : modèle pour la thérapie cellulaire et génique autologue de l'hémophilie B et modèle préclinique chez le primate

Luce, E. (2017) · theses.fr (ABES) · doi:10.70675/ac4516a9z0ec1z4655z97daz547d512b3fc9

Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer

Auboyer, L. (2018) · theses.fr (ABES) · doi:10.70675/07243ef7zb974z4ad8z97d9zd046801798b1

Molecular mechanisms of action of MT-MMPs involved in the pathogenesis of Alzheimer’s disease

García‐González, L. (2020) · theses.fr (ABES) · doi:10.70675/a04672c0z1f4az472ezbcd5zbea446eac50c

MT5-MMP promotes neuroinflammation, pathogenic processing of amyloid precursor protein and synaptic dysfunction at early stages in an Alzheimer's disease model

Piłat, D. (2021) · theses.fr (ABES) · doi:10.70675/0050afedz3f0bz461fzafefz4b4742f76a57

Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy

Goncalves, A. (2020) · theses.fr (ABES) · doi:10.70675/b42db6dez88a0z4a14z93eez8f51d19d46f5

Étude des perturbations astrocytaires sous l’influence de l’apolipoprotéine E4 : implications et applications dans la maladie d’Alzheimer

Arnaud, L. (2021) · theses.fr (ABES) · doi:10.70675/11e3cc48zf040z4b8azb1d3zb7f6a6eed96b

Genetic associations in sepsis and ARDS

Moroniti, J. J., Rameshchandran, P. M., Guo, M., Labuda, V., Chandy, M., & Leligdowicz, A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1864880

Human iPSC-Derived Brain Cells, Organoids, and Organoids-on-Chips: Advancing Neurological Disease Modeling to Improve Clinical Outcome

Burdman, G., Hanna, M., Yndart, A., Vashist, A., & Lakshmana, M. K. (2026) · Cells · doi:10.3390/cells15191768

Human Induced Pluripotent Stem Cells in Rare Neurological Disorders: Opportunities and Challenges for Disease Modeling and Drug Discovery

Harej, A., Rački, V., Belančić, A., Križ, J., Vitezić, D., Mršić‐Pelčić, J., Acharya, G., Varshney, M., & Pilipović, K. (2026) · Stem Cells International · doi:10.1155/sci/1130043

Human Stem Cell Approaches to Understanding and Treating Alzheimer’s Disease

Goldstein, L. S. B. (2013) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-36648-2_7

Induced Pluripotent Stem Cells from Familial Alzheimer's Disease Patients Differentiate into Mature Neurons with Amyloidogenic Properties

Mahairaki, V., Ryu, J., Peters, A., Chang, Q., Li, T., Park, T. S., Burridge, P. W., Talbot, C. C., Asnaghi, L., Martin, L. J., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0511 · Cited by 120

iPSC Modeling of Presenilin1 Mutation in Alzheimer's Disease with Cerebellar Ataxia

Li, L., Roh, J. H., Chang, E. H., Lee, Y. K., Lee, S., Kim, M., Koh, W., Chang, J. W., Kim, H. J., Nakanishi, M., et al. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.5.350 · Cited by 32

P1–091: Modeling Alzheimer's disease using induced pluripotent stem cells from familial and sporadic Alzheimer's disease patients

Shirotani, K., Kondo, T., Asai, M., Tsukita, K., Watanabe, K., Maruyama, K., Murakami, K., Irie, K., Klein, W. L., Mori, H., et al. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.05.312 · Cited by 1

Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

Israel, M. A., Yuan, S. H., Bardy, C., Reyna, S. M., Mu, Y., Herrera, C., Hefferan, M. P., Van Gorp, S., Nazor, K. L., Boscolo, F. S., et al. (2012) · Nature · doi:10.1038/nature10821 · Cited by 1,253

S5‐01‐02: Development of an induced pluripotent stem cell (iPSC) Alzheimer's disease model using PSEN1 mutant fibroblasts

Sproul, A. A., Jacob, S., Nestor, M. W., Keilani, S., Jean, Y., Kahler, D. J., Santa‐María, I., Steele, J., Crary, J. F., Troy, C. M., et al. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.1945 · Cited by 4